What You Should Know
- Cedars-Sinai has secured a $5.05M ARPA-H contract to build KronosRx, an AI platform that predicts drug toxicity by pairing millions of electronic health records with "patient avatars"—human stem-cell-derived organoids.
- The strategic initiative aims to solve the
Read More
KronosRx: How Cedars-Sinai is Using AI ‘Avatars’ to Replace Animal Testing”
































































